Exclusive-Meta says EU antitrust regulators are discriminating against its business model
BRUSSELS (Reuters) -Meta Platforms on Friday criticised EU antitrust regulators for moving the goalpost as the U.S. company seeks to comply with an order targeting its pay-or-consent business model.
The tech giant said the European Commission had discriminated against its business model and that it had nevertheless engaged constructively in discussions and introduced extensive changes.
"We are confident that the range of choices we offer people in the EU doesn't just comply with what the EU's rules require - it goes well beyond them," a Meta spokesperson said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
We Think MPH Health Care's (FRA:93M1) Healthy Earnings Might Be Conservative
MPH Health Care AG's (FRA:93M1) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some analysis to find out why and believe that investors might be missing some encouraging factors contained in the earnings. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To properly understand MPH Health Care's profit results, we need to consider the €31m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. MPH Health Care took a rather significant hit from unusual items in the year to December 2024. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. As we mentioned previously, the MPH Health Care's profit was hampered by unusual items in the last year. Because of this, we think MPH Health Care's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! And on top of that, its earnings per share increased by 8.5% in the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. Our analysis shows 6 warning signs for MPH Health Care (2 are a bit unpleasant!) and we strongly recommend you look at these before investing. This note has only looked at a single factor that sheds light on the nature of MPH Health Care's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
How to invest £500 a month in a Stocks & Shares ISA and aim for £1m
Investing £500 a month in a Stocks and Shares ISA, with the goal of reaching £1m, is a classic demonstration of the power of compound returns and the importance of starting early. The principle is simple: by consistently investing a fixed amount and allowing returns to compound over time, wealth can grow exponentially. This is not just theoretical. Historical data from the S&P 500, the world's most-watched stock market index, shows why a 10% annual return is a reasonable long-term expectation for equity investors. The S&P 500 has delivered an average annual return of about 10% since 1957, including dividends. This figure is not a guarantee for every year — returns can swing wildly from one year to the next — but over decades, the average holds remarkably steady. For example, over the last 30 years, the S&P 500's average annualised return has been around 9% to 10%, even after accounting for periods of dramatic losses like the dot-com bust and the global financial crisis. Over the last 10 years, the average has been even higher, at approximately 11.3% annually. These numbers illustrate that, despite short-term volatility, patient investors who stay the course are often rewarded. The real magic happens when investing starts early. With £500 invested each month at a 10% annual return, the compounding effect means that after 10 years, the balance could exceed £100,000, but after 30 years, that sum grows to over £1.1m. The vast majority of this final amount comes not from the contributions, but from the interest earned on previous gains. This is why time in the market is so valuable: the longer the money has to grow, the more powerful compounding becomes. Planning for the future by investing early and consistently is the surest way to harness the full potential of the stock market's long-term returns. Of course, the actual investing can be the hard part. Novice investors often make the wrong decisions and can lose money. The Monks Investment Trust (LSE:MNKS) is a long-established global investment trust managed by Baillie Gifford, with a focus on achieving long-term capital growth rather than income. Investors may be more familiar with its larger sibling, Scottish Mortgage Investment Trust. Its approach is patient and actively managed, seeking out a diversified range of growth stocks from around the world. The portfolio is spread across regions including North America, Europe, the UK, Japan, developed Asia, and emerging markets, with significant allocations to sectors such as technology, industrials, consumer discretionary, and financials. This broad diversification helps to reduce risk and smooth out returns over time. As such, it may be a good place to start for novice investors looking to achieve immediate diversification. Performance data shows that Monks has delivered strong long-term results, with a share price total return of approximately 198% over the past 10 years and a net asset value (NAV) total return of 192% over the same period. Risks? Well, gearing — borrowing to invest — is always a concern as this can magnify any losses. However, I certainly believe it's an investment worth considering. It's also present in my daughter's pension and mine. The post How to invest £500 a month in a Stocks & Shares ISA and aim for £1m appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool James Fox has positions in Scottish Mortgage Investment Trust Plc and The Monks Investment Trust Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
M&A News: OpenAI Acqui-Hires Crossing Minds amid Meta Poaching Spree
Microsoft-backed OpenAI (MSFT) has hired the entire team from Crossing Minds, which is a startup that has raised $13.5 million in funding (according to TechCrunch) to build AI recommendation tools for online shopping platforms. Crossing Minds announced the news on its website by stating that it was excited to join OpenAI and support its mission to make artificial general intelligence helpful for everyone. The team said it's eager to learn, contribute, and help shape the future of AI together with OpenAI. Confident Investing Starts Here: It is worth noting that this move is considered an 'acqui-hire.' This means that OpenAI mainly acquired the startup in order to bring in its talented team. The timing is notable, as OpenAI has recently seen some of its researchers leave for rival companies, especially Meta Platforms (META), which is aggressively pushing to become the leader in the AI market. Indeed, Meta has hired several researchers from OpenAI to work on its 'superintelligence' projects. According to The Wall Street Journal, Meta brought in Lucas Beyer, Alexander Kolesnikov, and Xiaohua Zhai, who helped start OpenAI's Zurich office last year. In a separate report, TechCrunch also revealed that Meta hired OpenAI researcher Trapit Bansal to focus on building better reasoning models. These moves highlight the increasing competition among tech giants to secure top AI talent. Is MSFT Stock a Buy? Turning to Wall Street, analysts have a Strong Buy consensus rating on MSFT stock based on 30 Buys and five Holds assigned in the last three months. Furthermore, the average MSFT price target of $521.41 per share implies 5.3% upside potential.
